22.04.2008 13:30:00

Connecticut IPA Selects NextGen(R) Enterprise Solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of ambulatory healthcare information systems and connectivity solutions, today announced that Fairfield County Physician Management Corporation/Norwalk IPA, an independent practice association in southwestern Connecticut, in conjunction with their partner Norwalk Hospital, has selected NextGen Healthcare’s suite of enterprise software solutions to enhance its clients’ clinical and administrative performance. Products selected for implementation into member practices include NextGen EMR (Electronic Medical Records), NextGen EPM (Enterprise Practice Management) and NextGen ICS (Image Control System). In securing this contract, NextGen Healthcare continues its national growth in the IPA market. With 200 members, FCPMC/Norwalk IPA currently represents more than half of the region’s physicians in practices of all sizes and specialties. Rollout of the NextGen technology is underway with four pilot practices. FCPMC/Norwalk IPA initiated a thorough search for health information technology and selected NextGen Healthcare because of its advanced enterprise functionality, company stability, and superior support and training services. "We evaluated more than 20 systems,” says Anthony DeFillippo, executive director of Fairfield County Physician Management Corporation and point person for the Norwalk Medical Community NextGen Initiative, "and we picked NextGen Healthcare because it is the clear industry leader. The depth and breadth of its ‘out-of-the-box’ content means we can implement the NextGen EMR across all of our specialties. At the same time, tools inherent to the software give us the flexibility to customize our workflow for maximum efficiency.” "Integration of NextGen EMR, NextGen EPM and NextGen ICS will provide opportunities for physicians to maximize revenue, reduce operational costs and improve clinical workflow,” DeFillippo adds. NextGen Healthcare’s specialty-specific content will equip physicians with a system designed for their individual specialties – with NextGen ICS supporting the move to a truly paperless office. Automation will also facilitate a reduction in transcription and medical records costs, and help to streamline workflow processes to maximize productivity. By using NextGen Healthcare’s structured data and built-in reporting tools in an enterprise environment, FCPMC/Norwalk IPA anticipates increased participation in pay-for-performance initiatives. In addition, FCPMC/Norwalk IPA, in partnership with Norwalk Hospital, will use NextGen products as the foundation for a community clinical network. Linkage to other community healthcare providers is expected to support involvement in clinical research programs and result in enhanced care. "Our goal is to use technology to improve care in our community,” says Peter Stovell, M.D., president of FCPMC/Norwalk IPA. "We invested significant time and effort in selecting a vendor partner that would support our vision. We came away convinced that NextGen Healthcare would not only help us meet, but ultimately exceed, our goals.” About NextGen Healthcare NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), develops and markets computer-based practice management and electronic medical records systems for medical group practices and Healthcare Systems. For more information about NextGen, please visit www.nextgen.com and www.qsii.com. This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Quality Systems Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Quality Systems Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%